Mats Lambe
- Oncology top 0.2%
- Cancer Risks and Factors 70
- Global Cancer Incidence and Screening 66
- Colorectal Cancer Screening and Detection 21
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 18
- Obstetrics and Gynecology top 1%
- Reproductive Medicine top 1%
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 27
- Prostate Cancer Diagnosis and Treatment 26
- Lung Cancer Treatments and Mutations 18
-
- Birth, Development, and Health 26
- Co-authors
- Hans GarmoLars HolmbergSven CnattingiusChung‐Cheng HsiehPär StattinAnna L.V. JohanssonMieke Van HemelrijckTherése Andersson
- Journals
- International Journal of Cancer (24 papers)Acta Oncologica (24 papers)Cancer Causes & Control (19 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Mats Lambe
282 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Oncology 4.9k
- Cancer Research 1.5k
- Obstetrics and Gynecology 661
- Reproductive Medicine 674
- Pulmonary and Respiratory Medicine 2.5k
Countries citing papers authored by Mats Lambe
This map shows the geographic impact of Mats Lambe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Lambe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Lambe more than expected).
Fields of papers citing papers by Mats Lambe
This network shows the impact of papers produced by Mats Lambe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Lambe. The network helps show where Mats Lambe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mats Lambe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 32 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 12 | |
| 10 | 2018 | 20 | |
| 11 | 2017 | 55 | |
| 12 | 2017 | 62 | |
| 13 | VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR MYELODYSPLASTIC SYNDROMES IN THE SWEDISH MDS-REGISTER | 2016 | 1 |
| 14 | 2015 | 27 | |
| 15 | 2015 | 66 | |
| 16 | 2012 | 31 | |
| 17 | Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study. | 2012 | 29 |
| 18 | 2011 | 81 | |
| 19 | 2004 | 3 | |
| 20 | 2002 | 129 |
About Mats Lambe
Mats Lambe is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Cancer Research, having authored 293 papers that have together received 12.0k indexed citations. Recurring topics across this work include Cancer Risks and Factors (70 papers), Global Cancer Incidence and Screening (66 papers), Prostate Cancer Treatment and Research (27 papers), Birth, Development, and Health (26 papers), Prostate Cancer Diagnosis and Treatment (26 papers), Colorectal Cancer Screening and Detection (21 papers), Lung Cancer Treatments and Mutations (18 papers) and Cancer, Lipids, and Metabolism (18 papers). The work is most often cited by research in Oncology (4.9k citations), Cancer Research (1.5k citations) and Obstetrics and Gynecology (661 citations). Mats Lambe has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Hans Garmo, Lars Holmberg, Sven Cnattingius, Chung‐Cheng Hsieh, Pär Stattin, Anna L.V. Johansson, Mieke Van Hemelrijck, Therése Andersson, Göran Walldius and Ingmar Jungner. Their work appears in journals such as International Journal of Cancer, Acta Oncologica, Cancer Causes & Control, European Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.